Lu, Lihong
Zhong, Ziwen
Gu, Jiahui
Nan, Ke
Zhu, Minmin http://orcid.org/0000-0002-4951-1421
Miao, Changhong
Clinical trials referenced in this document:
Documents that mention this clinical trial
ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy
https://doi.org/10.1186/s10020-021-00339-7
Funding for this research was provided by:
National Natural Science Foundation of China (81871590)
Article History
Received: 16 February 2021
Accepted: 1 July 2021
First Online: 8 July 2021
Declarations
:
: The study complied with the Declaration of Helsinki and was approved by the Ethics Committee of Huzhou Central Hospital (license number: 20191209–01), and written informed consent was obtained from all subjects. The present study complied with the Guide for the Care and Use of Laboratory Animals of Shanghai Medical College at Fudan University and was performed according to the Institutional Guidelines for Animal Research and the Guide for the Care and Use of Laboratory Animals published by the US NIH (2011).
: Not applicable.
: The authors declare that they have no competing interests.